Search research articles
Contact Us
Filters
Showing results (101-110 of 149) with videos related to
Page
of 15
Sort By:
Neuropharmacology
|
January 10, 2020
Attenuated dopamine receptor signaling in nucleus accumbens core in a rat model of chemically-induced neuropathy
Dana E Selley, Matthew F Lazenka, Laura J Sim-Selley, et al.
Journal of Medicinal Chemistry
|
May 24, 2021
Structure-Based Design and Development of Chemical Probes Targeting Putative MOR-CCR5 Heterodimers to Inhibit Opioid Exacerbated HIV-1 Infectivity
Boshi Huang, Huiqun Wang, Yi Zheng, et al.
Journal of Medicinal Chemistry
|
October 23, 2013
Design, synthesis, and biological evaluation of 14-heteroaromatic-substituted naltrexone derivatives: pharmacological profile switch from mu opioid receptor selectivity to mu/kappa opioid receptor dual selectivity
Yunyun Yuan, Saheem A Zaidi, Orgil Elbegdorj, et al.
ACS Chemical Neuroscience
|
July 21, 2012
Characterization of 6α- and 6β-N-heterocyclic substituted naltrexamine derivatives as novel leads to development of mu opioid receptor selective antagonists
Yunyun Yuan, Guo Li, Hengjun He, et al.
Journal of Medicinal Chemistry
|
December 20, 2022
Structural Alterations of the "Address" Moiety of NAN Leading to the Discovery of a Novel Opioid Receptor Modulator with Reduced hERG Toxicity
Hongguang Ma, Piyusha P Pagare, Mengchu Li, et al.
Journal of Neurochemistry
|
January 5, 2013
Striatal CB1 and D2 receptors regulate expression of each other, CRIP1A and δ opioid systems
Lawrence C Blume, Caroline E Bass, Steven R Childers, et al.
Journal of Medicinal Chemistry
|
February 10, 2009
Design, synthesis, and biological evaluation of 6alpha- and 6beta-N-heterocyclic substituted naltrexamine derivatives as mu opioid receptor selective antagonists
Guo Li, Lindsey C Aschenbach, Jianyang Chen, et al.
Neuropharmacology
|
January 26, 2016
Early adolescent nicotine exposure affects later-life cocaine reward in mice
Mai Alajaji, Matthew F Lazenka, Dena Kota, et al.
ACS Chemical Neuroscience
|
December 31, 2015
17-Cyclopropylmethyl-3,14β-dihydroxy-4,5α-epoxy-6β-(4'-pyridylcarboxamido)morphinan (NAP) Modulating the Mu Opioid Receptor in a Biased Fashion
Yan Zhang, Dwight A Williams, Saheem A Zaidi, et al.
Bioorganic Chemistry
|
May 26, 2024
Blocking potential metabolic sites on NAT to improve its safety profile while retaining the pharmacological profile
Rachael Flammia, Boshi Huang, Piyusha P Pagare, et al.
Page
of 15
Search research articles
Search
Showing results (101-110 of 149) with videos related to
Sort By:
Page
of 15
Neuropharmacology
|
January 10, 2020
Attenuated dopamine receptor signaling in nucleus accumbens core in a rat model of chemically-induced neuropathy
Dana E Selley, Matthew F Lazenka, Laura J Sim-Selley, et al.
Journal of Medicinal Chemistry
|
May 24, 2021
Structure-Based Design and Development of Chemical Probes Targeting Putative MOR-CCR5 Heterodimers to Inhibit Opioid Exacerbated HIV-1 Infectivity
Boshi Huang, Huiqun Wang, Yi Zheng, et al.
Journal of Medicinal Chemistry
|
October 23, 2013
Design, synthesis, and biological evaluation of 14-heteroaromatic-substituted naltrexone derivatives: pharmacological profile switch from mu opioid receptor selectivity to mu/kappa opioid receptor dual selectivity
Yunyun Yuan, Saheem A Zaidi, Orgil Elbegdorj, et al.
ACS Chemical Neuroscience
|
July 21, 2012
Characterization of 6α- and 6β-N-heterocyclic substituted naltrexamine derivatives as novel leads to development of mu opioid receptor selective antagonists
Yunyun Yuan, Guo Li, Hengjun He, et al.
Journal of Medicinal Chemistry
|
December 20, 2022
Structural Alterations of the "Address" Moiety of NAN Leading to the Discovery of a Novel Opioid Receptor Modulator with Reduced hERG Toxicity
Hongguang Ma, Piyusha P Pagare, Mengchu Li, et al.
Journal of Neurochemistry
|
January 5, 2013
Striatal CB1 and D2 receptors regulate expression of each other, CRIP1A and δ opioid systems
Lawrence C Blume, Caroline E Bass, Steven R Childers, et al.
Journal of Medicinal Chemistry
|
February 10, 2009
Design, synthesis, and biological evaluation of 6alpha- and 6beta-N-heterocyclic substituted naltrexamine derivatives as mu opioid receptor selective antagonists
Guo Li, Lindsey C Aschenbach, Jianyang Chen, et al.
Neuropharmacology
|
January 26, 2016
Early adolescent nicotine exposure affects later-life cocaine reward in mice
Mai Alajaji, Matthew F Lazenka, Dena Kota, et al.
ACS Chemical Neuroscience
|
December 31, 2015
17-Cyclopropylmethyl-3,14β-dihydroxy-4,5α-epoxy-6β-(4'-pyridylcarboxamido)morphinan (NAP) Modulating the Mu Opioid Receptor in a Biased Fashion
Yan Zhang, Dwight A Williams, Saheem A Zaidi, et al.
Bioorganic Chemistry
|
May 26, 2024
Blocking potential metabolic sites on NAT to improve its safety profile while retaining the pharmacological profile
Rachael Flammia, Boshi Huang, Piyusha P Pagare, et al.
Page
of 15